Equities

Beijing Foyou Pharma Co Ltd

601089:SHH

Beijing Foyou Pharma Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)14.40
  • Today's Change-0.18 / -1.23%
  • Shares traded1.28m
  • 1 Year change-15.24%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,5052,541534
Total Receivables, Net447471397
Total Inventory307339322
Prepaid expenses442124
Other current assets, total260.310.31
Total current assets3,3293,3721,278
Property, plant & equipment, net983780727
Goodwill, net------
Intangibles, net150143144
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets4,5484,3222,157
LIABILITIES
Accounts payable132144130
Accrued expenses188196163
Notes payable/short-term debt554070
Current portion long-term debt/capital leases252118
Other current liabilities, total598652486
Total current liabilities9981,053866
Total long term debt456250
Total debt124123138
Deferred income tax181917
Minority interest8.124.553.83
Other liabilities, total109.504.14
Total liabilities1,0791,148942
SHAREHOLDERS EQUITY
Common stock480480360
Additional paid-in capital1,6621,662146
Retained earnings (accumulated deficit)1,3261,032709
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity3,4683,1741,215
Total liabilities & shareholders' equity4,5484,3222,157
Total common shares outstanding480480480
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.